Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A decisional algorithm to start iron chelation in patients with beta thalassemia.
Danjou F, Cabantchik ZI, Origa R, Moi P, Marcias M, Barella S, Defraia E, Dessì C, Foschini ML, Giagu N, Leoni GB, Morittu M, Galanello R. Danjou F, et al. Among authors: origa r. Haematologica. 2014 Mar;99(3):e38-40. doi: 10.3324/haematol.2013.098202. Haematologica. 2014. PMID: 24598857 Free PMC article. No abstract available.
Nephrological Complications in Hemoglobinopathies: SITE Good Practice.
Ruffo GB, Russo R, Casini T, Lombardini L, Orecchia V, Voi V, Origa R, Forni GL, Marchetti M, Gigante A, Garibotto G, Maggio A, De Franceschi L. Ruffo GB, et al. Among authors: origa r. J Clin Med. 2023 Dec 2;12(23):7476. doi: 10.3390/jcm12237476. J Clin Med. 2023. PMID: 38068528 Free PMC article.
Management of the Sickle Cell Trait: An Opinion by Expert Panel Members.
Pinto VM, De Franceschi L, Gianesin B, Gigante A, Graziadei G, Lombardini L, Palazzi G, Quota A, Russo R, Sainati L, Venturelli D, Forni GL, Origa R. Pinto VM, et al. Among authors: origa r. J Clin Med. 2023 May 12;12(10):3441. doi: 10.3390/jcm12103441. J Clin Med. 2023. PMID: 37240547 Free PMC article. Review.
Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload.
Piga A, Galanello R, Forni GL, Cappellini MD, Origa R, Zappu A, Donato G, Bordone E, Lavagetto A, Zanaboni L, Sechaud R, Hewson N, Ford JM, Opitz H, Alberti D. Piga A, et al. Among authors: origa r. Haematologica. 2006 Jul;91(7):873-80. Haematologica. 2006. PMID: 16818273 Clinical Trial.
90 results